Mednax (MD) Reports In-Line Q4 EPS; Guides Q1 EPS Below Views

Mednax (NYSE: MD) reported Q4 EPS of $1.19, in-line with the analyst estimate of $1.19. Revenue for the quarter came in at $404.9 million versus the consensus estimate of $410.05 million.

Mednax sees FY2012 EPS of $0.96-$1.02, versus the consensus of $1.04.

For earnings history and earnings-related data on Mednax (MD) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Inhibrx, Inc. (INBX) Misses Q2 EPS by 54c
• KULR Technology Group (KULR) Misses Q2 EPS by 39c